Imagine If Health

Capture Real-World Data, in Real Time

Embrace real-world data and power better decision making

Together, Imagine If Health and the Gibbs lab at the WEHI, are working together to enable pharmaceutical and biotech companies to rapidly and efficiently collect structured real-world data (RWD) alongside their oncology and haematology Medicines Access Programs.

RWD is highly valuable in pharmaceutical decision-making, providing companies and healthcare professionals a greater understanding of how patients respond to treatments outside of the strict conditions of clinical trials. Medicines Access Programs provide an avenue for companies to gather rich data across a diverse and less restricted patient population.

Partnering with the experts at the WEHI allows strict governance and academic credibility to collect data appropriately. System integration means that the data can be collected in real time which provides huge advantages to companies looking to leverage this data internally or externally.

Now you can capture the immense value of RWD alongside your active oncology and haematology Medicines Access Programs

There is potential to reap extraordinary benefits from RWD.

Technology can enable the rapid and seamless collection of data better than ever before. Collect rich patient data alongside your MAP, in real-time, to help improve access to medicines.

Ask Us how

A Special Partnership

Imagine If Health and the Gibbs lab at WEHI are working to enable innovative medicines companies to more easily, quickly and cost-effectively collect real world data (RWD) alongside their oncology and haematology Medicines Access Programs.

Describe real world clinical and tumour characteristics of patients
Document incidence of adverse events resulting in treatment discontinuation, dose delays or dose reductions as well as adverse events of special interests
Describe progression free survival and determine overall survival
Explore the natural disease trajectory post disease progression, including subsequent lines of treatment

About WEHI and the Gibbs lab

WEHI (Walter and Elize Hall Institute of Medical Research) is where the world’s brightest minds collaborate and innovate to make life-changing scientific discoveries that help people live healthier for longer. Our medical researchers have been serving the community for more than 100 years, making transformative discoveries in cancers, infectious and immune diseases, developmental disorders, and healthy ageing. The Gibbs lab focuses on clinical data, clinical trials and biomarkers in cancer. The lab employs over 50 staff, with 21 clinicians covering expertise and registries in almost all solid cancers, and has led several world-first efforts in co-ordinating national trial activity. Find out more at www.wehi.edu.au

How It Works

Many current applications rely on slow, manual integration of datasets, rather than the access to application programming interfaces (APIs) that allow the seamless linkage between different sources of data.

The integration of The Gibbs Labs RWD collection study into an active Medicines Access Program operating on the Imagine If Health platform enables the compliant collection of existing structured patient data and a HCP communication channel to be fed directly into a real-world evidence collection study.

By running a real-world evidence study alongside the MAP, there can be a direct, timely and more seamless connection for prescribing doctors to participate in the RWE study, data can be collected in a timely manner, delivering value and insights back to the pharmaceutical company faster.

Here's just some of what the platform can enable:

Trigger pharmaceutical company email request for doctor participation through MAP platform
Automatically send emails to prescribing doctors, at the right time of treatment, to input required patient information into the RWE study
Compliantly map and sync required patient information directly from the MAP into the RWE collection portal
Trigger automations based on drug/patient treatment plan

Extraordinary Value From Real-World Data

Capture Real-World Data, in Real Time

Embrace real-world data and power better decision making

There is potential to reap extraordinary benefits from RWD.

Imagine if…Life Science companies could easily, quickly and compliantly capture RWD from their Medicine Access Programs to better understand safety and efficacy, measure outcomes, predict disease progression, and ultimately help ensure the right medicines are getting to the right patients faster.

A Special Partnership

“The integration of WEHI supports companies with medicines in oncology and haematology to more seamlessly include real-world evidence collection in a robust and structured manner. When collected in real-time, this evidence can offer huge value and help support better decision making.”

How It Works

Let's chat about RWD integration to maximise the value of your Medicines Access Program.